Telemos Capital has acquired Helios, a leading global healthcare communications firm, from NorthEdge, following the company's significant growth in revenue and operations.
Target Information
Helios is a full-service, independent global healthcare communications and strategic consultancy based in Cheshire. The company specializes in providing tailored solutions to global pharmaceutical clients, covering a diverse range of services such as medical writing, advisory boards, training, and symposia.
Ranking 17th on the 2020 Sunday Times FastTrack 100, Helios has demonstrated impressive growth driven by a commitment to excellence in service delivery, underpinned by significant investments in its workforce and a strong team culture.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare communications industry in the UK has seen remarkable growth in recent years, fueled by the increasing need for pharmaceutical companies to effectively engage with healthcare professionals and
Similar Deals
Aya Healthcare → Locum’s Nest
2025
Foresight Group → MyWay Digital Health Ltd
2025
Keensight Capital → Bedfont Scientific
2025
Calibre Scientific → Greyhound Chromatography and Allied Chemicals Ltd.
2024
Calibre Scientific → Invitech Ltd.
2024
Telemos Capital
invested in
Helios
in 2024
in a Other Private Equity deal